- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 15.52M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.66M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.61M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 15.67M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 15.58M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $9.57M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $13.5M |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $28.77M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $27.55M |
| Capex | Q3 2025 · Sep 30, 2025 | $26.05M |
| Capex | Q3 2025 · Sep 30, 2024 | $19.44M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $168.27M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $94.51M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $65.63M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $129.5M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $7.5M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $7.5M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $130.63M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $76.12M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $84.81M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.05B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $980.16M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $282.36M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $234.8M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $513.92M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $541.27M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $493.52M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $424.41M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.57B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.52B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $2.50 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $6.10 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $2.73 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $6.15 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.53 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $6.15 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $2.78 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $6.23 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $6.25M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $19.91M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $6.29M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $19.68M |
| Net Income | Q3 2025 · Sep 30, 2025 | $39.24M |
| Net Income | Q3 2025 · Sep 30, 2025 | $95.17M |
| Net Income | Q3 2025 · Sep 30, 2024 | $42.79M |
| Net Income | Q3 2025 · Sep 30, 2024 | $95.85M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $30.38M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $95.24M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $22.79M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $60.98M |
| Revenue | Q3 2025 · Sep 30, 2025 | $382.66M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.13B |
| Revenue | Q3 2025 · Sep 30, 2024 | $340.2M |
| Revenue | Q3 2025 · Sep 30, 2024 | $938.03M |